Safety Monitoring and Reporting in Clinical Trials Involving Therapeutic Goods
In 2016 National Health and Medical Research Council (NHMRC) released new guidance on Safety Monitoring and Reporting in Clinical Trials Involving Therapeutic Goods (the Guidance) to replace the 2009 Australian Health Ethics Committee Position Statement of the same name (the Position Statement). In 2018 the NHMRC released new guidance on Reporting of Serious Breaches of